New drug trial aims to stop Alzheimer's before it starts
NCT ID NCT07399171
Summary
This study is testing whether an investigational drug called HT-4253 can prevent Alzheimer's disease in people who carry a specific genetic risk factor (APOE4) and show early signs of brain changes. About 112 participants, aged 50-75 and without an Alzheimer's diagnosis, will receive either the drug or a placebo for 48 weeks. The main goal is to see if the drug can lower a blood test score that indicates a high risk of developing Alzheimer's brain plaques.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMERS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cleveland Clinic Abu Dhabi
Abu Dhabi, United Arab Emirates
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.